3rd July 2017

Atnahs Acquires Rights for Bonviva® and Bondronat®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of worldwide rights...

More information
3rd January 2017

Atnahs Acquires Kytril®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Kytril® from...

More information
3rd June 2016

Statement Regarding Recent Media Coverage

Basildon, UK, 3 June 2016 – Atnahs Pharma is providing the following statement in relation to...

More information
11th May 2016

Atnahs Acquires Naproxen Suspension in the US

Basildon, UK, May 11 2016 – Atnahs Pharma US Limited (“Atnahs”) is pleased to announce that...

More information
31st March 2016

Atnahs Acquires Majority Stake in Pharmanovia A/S in Denmark

Basildon, UK, March 31 2016 – Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the...

More information
31st January 2016

Atnahs Acquires Naproxen Suspension in the US

Basildon, UK, January 31 2016 – Atnahs Pharma US Limited (“Atnahs”) is pleased to announce the...

More information
2nd April 2015

Atnahs Acquires Naprosyn®, Anaprox® and Toradol®

Basildon, UK, April 2015 – Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition...

More information
14th March 2014

Atnahs Acquires Dipentum®

Basildon, UK, March 2014 – Atnahs Pharma UK Limited (“Atnahs”) is delighted to announce that, as...

More information